Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Frank Mathias Insider Profile
4 Followers
Frank Mathias, Director at Medigene, holds ― shares in Medigene (Ticker: GB:0QGJ), holds 20.00K shares in Oxford BioMedica (Ticker: OXBDF). Most recently, Frank Mathias Bought ― shares of Medigene on May 15, 2024 for an estimated value of 6.96K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-8.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Frank Mathias holds in companies
Most Profitable Insider Trade
The most profitable trade made by Frank Mathias
Frank Mathias's Trading History
Medigene
May 15, 2024
Director
Informative Buy
6.96K
―
Oxford BioMedica
Sep 20, 2023
Chief Executive Officer
Informative Buy
55.00K
$92.10K
List of latest transactions for each holding click on a transaction to see Frank Mathias's performance on stock
You May Also Like
Frank Mathias insider profile FAQ
What is the percentage of profitable transactions made by Frank Mathias?
The percentage of profitable transactions made by Frank Mathias is 33%.
What is the average return per transaction made by Frank Mathias?
The average return per transaction made by Frank Mathias is -8.10%.
What stocks does Frank Mathias hold?
Frank Mathias holds: GB:0QGJ, OXBDF stocks.
What was Frank Mathias’s latest transaction?
Frank Mathias latest transaction was an Informative Buy of €6.96K.
What was Frank Mathias's most profitable transaction?
Frank Mathias’s most profitable transaction was an Informative Buy of OXBDF stock on September 20, 2023. The return on the trade was 31.90%.
What is Frank Mathias's role in Medigene?
Frank Mathias's role in Medigene is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.